Study shows major shift toward later-onset myasthenia gravis
The age of MG symptoms onset has gotten significantly older in the past five decades, with very late onset making up 45% of new diagnoses.
The age of MG symptoms onset has gotten significantly older in the past five decades, with very late onset making up 45% of new diagnoses.
The Myasthenia Gravis Activities of Daily Living scale offers a quick snapshot of disease severity.
Glucocorticoids are a cornerstone of MG treatment, but prolonged use can lead to complications and higher healthcare costs.
A large national study from Korea found an association between higher BMI and risk of developing myasthenia gravis.
This metaphor makes invisible symptoms visible and helps others understand that energy is finite.
A new study reveals a distinct immune signature associated with difficult-to-treat MG that may lead to new treatment targets.
Controlling symptoms of myasthenia gravis before conception is key to achieving the best possible outcomes, researchers say.
People of color face a higher disease burden and more severe hospital outcomes from myasthenia gravis compared to white patients.
A large Chinese study revealed key differences in myasthenia gravis (MG) across childhood, adulthood and older age.
New research finds people living with MG experience higher levels of depression, anxiety and sleep disturbances compared to healthy peers.